FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4310798814> ?p ?o ?g. }

• W4310798814 abstract "Structured Abstract Importance Patients with mesothelioma often have next generation sequencing (NGS) of their tumor. Tumor-only NGS may incidentally identify germline pathogenic or likely pathogenic (P/LP) variants despite not being designed for this purpose. It is unknown how frequently patients with mesothelioma have germline P/LP variants incidentally detected via tumor-only NGS. Objective To determine the prevalence of incidental germline P/LP variants detected via tumor-only NGS of mesothelioma. Design A series of 161 unrelated patients with mesothelioma had tumor-only NGS and germline NGS. These assays were compared to determine which P/LP variants identified via tumor-only NGS were of germline origin. Setting This was an observational study from a high-volume mesothelioma program. All patients enrolled on Institutional Review Board-approved protocols. Participants 161 unrelated patients with pleural, peritoneal, or bicavitary mesothelioma. Intervention(s) (for clinical trials) or Exposure(s) (for observational studies) No therapeutic interventions were used. Main Outcome(s) and Measure(s) The proportion of patients with mesothelioma who had P/LP germline variants incidentally detected via tumor-only NGS. Results Most (78%) patients had potentially incidental P/LP germline variants. The positive predictive value of a potentially incidental germline P/LP variant on tumor-only NGS was 20%. Overall, 16% of patients carried a P/LP germline variant. Germline P/LP variants were identified in ATM, ATR, BAP1, CHEK2, DDX41, FANCM, HAX1, MRE11A, MSH6, MUTYH, NF1, SAMD9L , and TMEM127 . Conclusions and Relevance Most (78%) patients with mesothelioma had potentially incidental germline P/LP variants on tumor NGS, but the positive predictive value of these was modest (20%). Of all patients, 16% had confirmed germline P/LP variants. Given the implications of a hereditary cancer syndrome diagnosis for preventive care and familial counseling, clinical approaches for addressing incidental P/LP germline variants in tumor-only NGS are needed.Tumor-only sequencing should not replace dedicated germline testing. Universal germline testing is likely needed for patients with mesothelioma. Key Points Question What proportion of patients with mesothelioma have pathogenic or likely pathogenic germline variants incidentally identified by tumor-only genomic profiling? Findings In this cohort study of 161 patients with mesothelioma, 78% of patients had potential germline variants that warranted further evaluation. Overall, 16% of patients had pathogenic or likely pathogenic germline variants initially identified via tumor-only genomic profiling. Meaning Tumor genomic profiling of mesothelioma frequently (78% of patients) identifies potential germline pathogenic/likely pathogenic variants that warrant dedicated germline evaluation. The high prevalence of germline variants (16%) in our series suggests universal genetic testing may be warranted for patients with mesothelioma." @default.
• W4310798814 created "2022-12-18" @default.
• W4310798814 creator A5000694161 @default.
• W4310798814 creator A5005423159 @default.
• W4310798814 creator A5014068842 @default.
• W4310798814 creator A5014389327 @default.
• W4310798814 creator A5017604098 @default.
• W4310798814 creator A5020474538 @default.
• W4310798814 creator A5021095019 @default.
• W4310798814 creator A5031731385 @default.
• W4310798814 creator A5039069744 @default.
• W4310798814 creator A5041428040 @default.
• W4310798814 creator A5046480613 @default.
• W4310798814 creator A5049078993 @default.
• W4310798814 creator A5053712180 @default.
• W4310798814 creator A5055204234 @default.
• W4310798814 creator A5058770723 @default.
• W4310798814 creator A5060699846 @default.
• W4310798814 creator A5067253402 @default.
• W4310798814 creator A5068884217 @default.
• W4310798814 creator A5069841345 @default.
• W4310798814 creator A5083807545 @default.
• W4310798814 creator A5086195902 @default.
• W4310798814 creator A5087795745 @default.
• W4310798814 creator A5090156519 @default.
• W4310798814 creator A5091700418 @default.
• W4310798814 date "2022-12-06" @default.
• W4310798814 modified "2023-10-01" @default.
• W4310798814 title "Prevalence of incidental germline variants detected via tumor-only mesothelioma genomic profiling" @default.
• W4310798814 cites W1599485646 @default.
• W4310798814 cites W1880027388 @default.
• W4310798814 cites W2023011946 @default.
• W4310798814 cites W2033990985 @default.
• W4310798814 cites W2044167464 @default.
• W4310798814 cites W2051978340 @default.
• W4310798814 cites W2117542219 @default.
• W4310798814 cites W2130634070 @default.
• W4310798814 cites W2145922766 @default.
• W4310798814 cites W2291531085 @default.
• W4310798814 cites W2293652792 @default.
• W4310798814 cites W2297062822 @default.
• W4310798814 cites W2309193218 @default.
• W4310798814 cites W2317355101 @default.
• W4310798814 cites W2329699996 @default.
• W4310798814 cites W2552027239 @default.
• W4310798814 cites W2728734374 @default.
• W4310798814 cites W2742577658 @default.
• W4310798814 cites W2790449611 @default.
• W4310798814 cites W2793330501 @default.
• W4310798814 cites W2806103948 @default.
• W4310798814 cites W2809494794 @default.
• W4310798814 cites W2884598605 @default.
• W4310798814 cites W2938922501 @default.
• W4310798814 cites W2973029757 @default.
• W4310798814 cites W2997140575 @default.
• W4310798814 cites W3011178889 @default.
• W4310798814 cites W3033124927 @default.
• W4310798814 cites W3095016275 @default.
• W4310798814 cites W3118983547 @default.
• W4310798814 cites W3184751628 @default.
• W4310798814 cites W4224251450 @default.
• W4310798814 cites W4280495268 @default.
• W4310798814 cites W4280578237 @default.
• W4310798814 cites W4288060409 @default.
• W4310798814 cites W4288685005 @default.
• W4310798814 doi "https://doi.org/10.1101/2022.12.06.22282680" @default.
• W4310798814 hasPublicationYear "2022" @default.
• W4310798814 type Work @default.
• W4310798814 citedByCount "0" @default.
• W4310798814 crossrefType "posted-content" @default.
• W4310798814 hasAuthorship W4310798814A5000694161 @default.
• W4310798814 hasAuthorship W4310798814A5005423159 @default.
• W4310798814 hasAuthorship W4310798814A5014068842 @default.
• W4310798814 hasAuthorship W4310798814A5014389327 @default.
• W4310798814 hasAuthorship W4310798814A5017604098 @default.
• W4310798814 hasAuthorship W4310798814A5020474538 @default.
• W4310798814 hasAuthorship W4310798814A5021095019 @default.
• W4310798814 hasAuthorship W4310798814A5031731385 @default.
• W4310798814 hasAuthorship W4310798814A5039069744 @default.
• W4310798814 hasAuthorship W4310798814A5041428040 @default.
• W4310798814 hasAuthorship W4310798814A5046480613 @default.
• W4310798814 hasAuthorship W4310798814A5049078993 @default.
• W4310798814 hasAuthorship W4310798814A5053712180 @default.
• W4310798814 hasAuthorship W4310798814A5055204234 @default.
• W4310798814 hasAuthorship W4310798814A5058770723 @default.
• W4310798814 hasAuthorship W4310798814A5060699846 @default.
• W4310798814 hasAuthorship W4310798814A5067253402 @default.
• W4310798814 hasAuthorship W4310798814A5068884217 @default.
• W4310798814 hasAuthorship W4310798814A5069841345 @default.
• W4310798814 hasAuthorship W4310798814A5083807545 @default.
• W4310798814 hasAuthorship W4310798814A5086195902 @default.
• W4310798814 hasAuthorship W4310798814A5087795745 @default.
• W4310798814 hasAuthorship W4310798814A5090156519 @default.
• W4310798814 hasAuthorship W4310798814A5091700418 @default.
• W4310798814 hasBestOaLocation W43107988141 @default.
• W4310798814 hasConcept C104317684 @default.
• W4310798814 hasConcept C109825262 @default.
• W4310798814 hasConcept C126322002 @default.
• W4310798814 hasConcept C142724271 @default.
• W4310798814 hasConcept C143998085 @default.

• next